Announcements Trials
Browse Landscape

Status

Not yet recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Observational 2

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Squamous Cell Carcinoma of Head and Neck 3Carcinoma 3Neoplasms 2Lung Neoplasms 2Head and Neck Neoplasms 2Vulvar Neoplasms 1Triple Negative Breast Neoplasms 1Thyroid Neoplasms 1Teratoma, Ovarian 1Struma Ovarii 1Salivary Gland Neoplasms 1Ovarian Neoplasms 1Oligodendroglioma 1Myelodysplastic Syndromes 1Metabolic Syndrome 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia 1Hemangioma, Cavernous, Central Nervous System 1Glioblastoma 1Genetic Predisposition to Disease 1Disease 1Diabetes Mellitus 1Cytopenia 1Cardiovascular Diseases 1Carcinoma, Squamous Cell 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Hepatocellular 1Astrocytoma 1

Interventions

pembrolizumab 185Gemcitabine 170Paclitaxel 152Carboplatin 137Bevacizumab 128Surveys and Questionnaires 118Cisplatin 115Docetaxel 114Blood Specimen Collection 110Cyclophosphamide 109Exercise 108Nivolumab 98Fluorouracil 90Capecitabine 86Dexamethasone 81Radiotherapy 80Irinotecan 74Standard of Care 69Pemetrexed 68Oxaliplatin 68Leucovorin 64Drug Therapy 64Cetuximab 60Erlotinib Hydrochloride 56Sorafenib 53atezolizumab 52Ipilimumab 51Doxorubicin 50trametinib 47Interviews as Topic 47

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Neoplasms × DNA × Clear all
NCT04620278 2026-01-06

Genetic Investigation of Cancer Predisposition

The University of Texas Health Science Center at San Antonio

Not yet recruiting
100 enrolled

Disease, Neoplasms, Genetic Predisposition to Disease

NCT00984035 2018-09-11

Investigation of Cisplatin-Related Kidney Toxicity

University of Chicago

Completed
102 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡